Page last updated: 2024-11-05

zonisamide and Delirium

zonisamide has been researched along with Delirium in 1 studies

Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.

Delirium: A disorder characterized by CONFUSION; inattentiveness; disorientation; ILLUSIONS; HALLUCINATIONS; agitation; and in some instances autonomic nervous system overactivity. It may result from toxic/metabolic conditions or structural brain lesions. (From Adams et al., Principles of Neurology, 6th ed, pp411-2)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Reinfeld, S1
Tejeda, CI1
Koola, MM1

Other Studies

1 other study available for zonisamide and Delirium

ArticleYear
Delirium in the Context of Zonisamide-Induced Toxic Epidermal Necrolysis.
    The primary care companion for CNS disorders, 2022, Feb-03, Volume: 24, Issue:1

    Topics: Delirium; Humans; Stevens-Johnson Syndrome; Zonisamide

2022